DATAMETREX AI LIMIT - DTMXF STOCK NEWS

Datametrex AI (TSXV:DM, FSE:D4G, OTC PINK:DTMXF) has announced significant changes in its leadership team and Board of Directors. Charles Park has stepped down as CEO and from the Board for personal reasons, effective September 10, 2024. In response, Chairman Paul Haber has assumed the role of CEO to ensure a smooth transition. The company has also appointed Richard Yoon to the Board of Directors. Yoon brings extensive experience in the telecommunications industry, having served as CEO of ZTE Canada and Redline Communications, and held key positions at companies like Huawei, Palm, TELUS, Bell, and Clearnet. The company expects to benefit from Yoon's expertise as it aims to strengthen its market position and drive growth.

Datametrex AI (TSXV:DM, OTC PINK:DTMXF) has implemented advanced AI technology at its Imagine Health Centres in Calgary and Edmonton, Alberta. The AI tools are designed to streamline patient care and enhance healthcare accessibility. Key features include:

1. Automated patient charting process
2. Dictation and generation of encounter notes
3. Seamless integration with Electronic Medical Record (EMR) system

The company expects this implementation to reduce manual note-taking time, allowing doctors to focus more on patient care. Datametrex aims to improve efficiency, reduce wait times, and provide more accessible healthcare solutions while maintaining strict privacy and security standards for patient data.

Datametrex AI (TSXV:DM, OTC PINK:DTMXF) has officially launched its play-to-earn mobile game, Cereal Crunch, on the Google Play Store. The game features unique match-3 mechanics, vibrant graphics, and challenging levels, aiming to captivate a wide audience in the mobile gaming market. CEO Charles Park expressed excitement about the launch, viewing it as a significant milestone in the company's expansion into the gaming sector.

Following this release, Datametrex plans to launch Cereal Crunch on additional platforms, including the Apple App Store, to broaden its reach. The company is committed to enhancing the game with future updates, including the introduction of play-to-earn mechanics.

Datametrex AI (TSXV:DM, FSE:D4G, OTC Pink:DTMXF) has successfully completed its vendor take-back (VTB) obligation for the acquisition of Imagine Health Centres. The company fulfilled a secured VTB note of $800,000, payable in installments over 6, 12, and 18 months, as outlined in their November 30, 2022 news release. This achievement demonstrates Datametrex's commitment to its financial obligations and ongoing support for Imagine Health's growth. CEO Charles Park emphasized that this strategic investment aligns with the company's broader vision to enhance access to quality healthcare services across Canada.

Datametrex AI (TSXV:DM, OTC PINK:DTMXF) has reported strong financial performance in its AI and Tech division for the first half of 2024. The company achieved revenue of approximately $1.3 million with expenses of $821K, resulting in a gross profit margin of about 37% from its IT services in Korea. This success is attributed to Datametrex's 'deep and narrow' strategic approach and its 'land and expand' strategy with key clients in the services, finance, and public sectors. CEO Charles Park expressed pride in the company's progress and confidence in sustaining this positive trajectory to deliver greater value to shareholders and partners.

Datametrex AI (TSXV:DM, FSE:D4G, OTC Pink:DTMXF) has successfully closed the final tranche of its non-brokered private placement financing, raising gross proceeds of $565,000. This brings the aggregate total to $1,521,909.30 across all 3 tranches. The final tranche consisted of 28,250,000 units at $0.02 per unit, each comprising one common share and one warrant. Warrants are exercisable at $0.05 for two years. Insiders participated with $190,000. The proceeds will be used for general corporate and working capital purposes. CEO Charles Park expressed delight in the successful closing, emphasizing investor trust and the financing's importance for growth and shareholder value.

Datametrex AI (TSXV: DM) (OTC Pink: DTMXF) has been granted a 30-day extension until August 29, 2024, to complete its non-brokered private placement of up to 75,000,000 units for total gross proceeds of up to $1,500,000. The company has successfully closed the first tranche of $645,000 and the second tranche of $311,409.29. Each unit consists of one common share and one warrant, with each warrant exercisable at CAD $0.05 for two years.

The net proceeds will be used for general corporate and working capital purposes. CEO Charles Park expressed satisfaction with the progress of the financing, stating it demonstrates investor confidence in the company's vision and capabilities.

Datametrex AI (OTC Pink: DTMXF) has closed the first tranche of its non-brokered private placement, raising $645,500 through the issuance of 32,275,000 units at $0.02 per unit. Each unit consists of one common share and one warrant, with warrants exercisable at $0.05 per share for two years. The proceeds will be used for general working capital. Notably, insiders subscribed for 3,000,000 units, classified as a related party transaction under MI 61-101 but exempt from formal valuation and minority approval requirements. The securities are subject to a four-month hold period as per Canadian laws.

Datametrex AI announced the addition of two new physicians to Imagine Health Centres. This move is expected to increase the annual revenue of the medical clinics by approximately $450,000 and improve the gross margin by $130,000. The addition aligns with the company's goal to enhance healthcare services and patient outcomes in Alberta. CEO Charles Park expressed excitement about the physicians' diverse backgrounds and dedication to patient care, anticipating a significant positive impact on the clinics and communities.